產(chǎn)品名稱(chēng) |
S194/5.XXO.BU.1 |
商品貨號(hào) |
B165643 |
Organism |
Mus musculus, mouse |
Cell Type |
B lymphocyte |
Product Format |
frozen |
Morphology |
lymphoblast |
Culture Properties |
suspension |
Biosafety Level |
1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
Disease |
plasmacytoma; myeloma |
Strain |
BALB/c |
Applications |
Resistant to 0.1 mM 5-bromo-2'-deoxyuridine. Derived from the S194/5.XXO-1 cell line (ATCC TIB-19). Tested and found negative for ectromelia virus (mousepox). |
Derivation |
Derived from the S194/5.XXO-1 cell line (ATCC TIB-19). |
Antigen Expression |
H-2d; PC.1 |
Genes Expressed |
immunoglobulin; monoclonal antibody; not secreted,H-2d; PC.1 |
Cellular Products |
immunoglobulin; monoclonal antibody; not secreted |
Comments |
Resistant to 0.1 mM 5-bromo-2'-deoxyuridine. Derived from the S194/5.XXO-1 cell line (ATCC TIB-19). Tested and found negative for ectromelia virus (mousepox). |
Complete Growth Medium |
Dulbecco's modified Eagle's medium, 90%; horse serum, 10%
|
Subculturing |
Medium Renewal: Every 2 to 3 days Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 10 exp5 cells/ml and maintain between 1 X 10 exp5 and 1 X 10 exp6 cells/ml. |
Isotype |
IgA (not secreted); kappa light chain (not secreted) |
Name of Depositor |
R Hyman, P Ralph, S Sarkar |
Deposited As |
Mus musculus |
References |
Hyman R, et al. Cell-specific antigens and immunoglobulin synthesis of murine myeloma cells and their variants. J. Natl. Cancer Inst. 48: 173-184, 1972. PubMed: 4119881
|